文章摘要
孙丽华,胡芳志.MCP-1在2型糖尿病中的作用[J].济宁医学院学报,2024,47(3):245-248
MCP-1在2型糖尿病中的作用
Advances in the study of the role of MCP-1 in type 2 diabetes mellitus
投稿时间:2023-05-15  
DOI:10.3969/j.issn.1000-9760.2024.03.018
中文关键词: 糖尿病;MCP-1;CCL2;糖尿病肾病;免疫
英文关键词: Diabetes;MCP-1;CCL2;Diabetic nephropathy;Immunity
基金项目:
作者单位E-mail
孙丽华 济宁医学院临床医学院, 济宁 272013  
胡芳志 济宁市第一人民医院内分泌与代谢科, 济宁 272011 hufangzhikaoyan123@163.com 
摘要点击次数: 50
全文下载次数: 33
中文摘要:
      2型糖尿病(T2DM)是一种常见的内分泌慢性代谢性疾病,其发病率逐年升高,呈现年轻化的趋势,且长期慢性高血糖易引起多种并发症,影响人类的生活质量,已成为严重危害人类生命健康的疾病,但对于其发病机制目前尚不明确。单核细胞趋化蛋白-1(monocyte chemotactic protein 1,MCP-1)作为CC趋化因子家族中的一员,参与多种自身免疫性疾病的发生发展。目前已有的研究结果显示,MCP-1与T2DM并发症中的大血管、微血管病变及神经病变相关联,可能参与其发病机制。本文就MCP-1在T2DM及其并发症中的研究进展作一论述。
英文摘要:
      Type 2 diabetes mellitus (T2DM) is a common endocrine chronic metabolic disease,the incidence of which is increasing year by year,presenting a trend of rejuvenation,and long-term chronic hyperglycemia is prone to cause a variety of complications,which affects the quality of life of the patients,and it has become a disease that seriously jeopardizes the life and health of human beings,but the pathogenesis of the disease is still not clear.As a member of the CC chemokine family,monocyte chemotactic protein 1 (MCP-1) is involved in the development of a variety of autoimmune diseases,and the Results of current studies have shown that MCP-1 is associated with macrovascular and microvascular lesions and neurological complications of T2DM,and may be involved in its pathogenesis.In this article,we discuss the research progress of MCP-1 in type 2 diabetes mellitus and its complications.
查看全文   查看/发表评论  下载PDF阅读器

分享按钮

漂浮通知

  X

近期,网上出现以《济宁医学院学报》杂志社的名义制造的虚假网站,诱骗作者在线投稿,骗取作者版面费或收取中介费,造成恶劣影响。在此提醒广大作者,审慎辨别,谨防上当。 投稿警示:我刊对所有来稿均不收取审稿费。 投稿方式:登录济宁医学院官方网站,在左下方点击“济宁医学院学报”进入《济宁医学院学报》网页,点击作者登录,注册新用户,然后在线投稿。